JENNIFER SPEARS: Open Payments
NPI 1932673589 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 21 payments from 8 companies in 2025. Trend: 2023 $44 · 2024 $70 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $260 |
| Hologic Sales and Service, LLC | 3 | $76 |
| Novo Nordisk Inc | 3 | $53 |
| Astellas Pharma US Inc | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| PFIZER INC. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: ZEPBOUND, APTIMA, Veozah, Ozempic, MOUNJARO, CAPLYTA, PAXLOVID, REXULTI.
Industry payments across TN — which companies pay providers there.
